Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Continued use of tirzepatide may reduce the survival rate of transferred fat or will cause engrafted fat to shrink
Generic catalog-wide figures cannot verify the specific material shipped
30, 2023, identified via electronic health records (EHR) How were participants evaluated
Saynor added that further price drops could follow as other generics enter the market
(Eli Lilly and Company, 2026)
First disclosed by Eli Lilly investigators in 2018 under the development code LY3298176, tirzepatide marked a deliberate departure from decades of incretin research that had focused almost exclusively on GLP-1 mono-agonism
US$ 22.71
US$ 21.93
US$ 22.89
